関連する実験動画
Updated: Feb 22, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.8K
CKDの合併症の発症における性差異
Gianmarco Lombardi1, Elisa De Tomi1, Chiara Lenoci1
1Section of Nephrology, Department of Medicine, Università degli Studi di Verona, Verona, Italy.
まとめ
慢性腎臓病 (CKD) を患っている男性は,ヘモグロビンと酸化がより速く低下し,副甲状腺ホルモンがより強く上昇します. しかし,これらの性特異的なCKD合併症パターンは,死亡リスクに影響を与えませんでした.
科学分野:
- ネフロロジーは腎臓科
- 内科内科は,内科の内科である.
- クリニック・リサーチ 臨床研究
背景:
- 慢性腎疾患 (CKD) の合併症における性差異に関する証拠は限られており,しばしば横断データに依存しています.
- 本研究では,CKDの合併症パラメータと性別の違いを縦断的に調べることによって,このギャップを埋めています.
研究 の 目的:
- 慢性腎臓病の合併症の臨床的および生化学的マーカーを縦断的に評価する.
- CKDの合併症の性別特異的経路を特定し,比較する.
- これらの合併症と男性と女性の死亡率との関連を調査する.
主な方法:
- 10年フォローアップしたCRICコホートの遡及的分析.
- ベースライン eGFR 20-70 mL/min/1.73 m2.2 を有する成人を含む.
- ヘモグロビン,CO2,カリウム,リン,PTH,SBPの縦断評価は,混合効果モデルと死亡率のコックス回帰を用いて,性別分層分析を行いました.
主要な成果:
- 男性は貧血,酸性,高カリミア,甲状腺機能障害の有病率が高く,女性は高リンパ血症の有病率が高かった.
- 縦断的に見ると,eGFRの悪化は,Hb,CO2,SBPの減少,K+,リン酸,iPTHの増加と相関していた.
- 男性は,HbとCO2の急激な減少と,女性と比較してiPTHのより顕著な上昇を示しました. 男性は全因死亡率が高かった.
結論:
- CKDの合併症の進行には,有意な性別の違いが存在し,男性は主要なパラメータのより急速な変化を経験しています.
- 合併症の経路が異なるにもかかわらず,性別はこれらの特定のCKD合併症に関連する死亡リスクに影響を与えませんでした.
関連する概念動画
01:25Chronic Kidney Disease I: Introduction
820
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
820
01:24Chronic Kidney Disease II: Clinical Manifestations
758
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
758
01:28Chronic Kidney Disease III: Interprofessional Care
503
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
267
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
267
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
363
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
363
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274